The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Expression of circulating miR375 and miR371 to differentiate teratoma and viable germ cell tumor in patients with post-chemotherapy residual disease.
 
Lucia Nappi
Honoraria - Astellas Pharma; Ipsen; Pfizer
Patents, Royalties, Other Intellectual Property - IVERMECTIN ANALOGUE COMPOUND THERAPEUTICS FOR HEAT SHOCK PROTEIN-27 (HSP27) INHIBITION, METHODS AND USES ASSOCIATED THEREWITH provisional number: 62/756,707
Travel, Accommodations, Expenses - Pfizer
 
Marisa Thi
No Relationships to Disclose
 
Nabil Adra
Research Funding - Genentech (Inst); Merck (Inst)
 
Ricardo Romao Nazario Leao
Travel, Accommodations, Expenses - Roche Pharma AG
 
Bernhard J. Eigl
Honoraria - AstraZeneca; Janssen; Merck; Pfizer; Roche Canada
Consulting or Advisory Role - AstraZeneca; Janssen; Merck; Roche Canada
Speakers' Bureau - Merck
Travel, Accommodations, Expenses - AstraZeneca; Janssen
 
Kim N. Chi
Honoraria - Astellas Pharma; Bayer; Janssen; Sanofi
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; ESSA; Janssen; Roche; Sanofi
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen (Inst); Lilly/ImClone (Inst); Merck (Inst); Roche (Inst); Sanofi (Inst); Tokai Pharmaceuticals (Inst)
 
Martin Gleave
Stock and Other Ownership Interests - OncoGenex
Honoraria - Astellas Pharma; Bayer; Genova Diagnostics; Janssen; Pfizer; Sanofi
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Genova Diagnostics; Janssen; Pfizer; Sanofi
Research Funding - Astellas Pharma; Bayer; Janssen
Patents, Royalties, Other Intellectual Property - OncoGenex - OGX-011, OGX-427; ST-CP; ST-POP
 
Alan So
No Relationships to Disclose
 
Peter C. Black
Consulting or Advisory Role - Abbvie; Amgen; Asieris Pharmaceuticals; Astellas Pharma; AstraZeneca; Bayer; Biosyent; Bristol-Myers Squibb; Ferring; Janssen Oncology; MDxHealth; Merck; Roche Canada; Sanofi; Urogen pharma
Speakers' Bureau - TerSera
Research Funding - GenomeDx; iProgen; Sitka
Patents, Royalties, Other Intellectual Property - 1. PCT/CA2014/000787. Canada. 2014-11-03 Cancer Biomarkers and Classifiers and uses thereof. 2. #61899648 United States. 2013-03-13 Bladder cancer signature.
Travel, Accommodations, Expenses - Sanofi
 
Robert James Hamilton
Honoraria - Abbvie; Amgen; Astellas Pharma; Bayer; Janssen
Research Funding - Bayer; Janssen
Travel, Accommodations, Expenses - Janssen
 
Siamak Daneshmand
Honoraria - Ferring; MDxHealth; Olympus; pacific edge; Photocure; QED Therapeutics; Spectrum Pharmaceuticals
Consulting or Advisory Role - Ferring; Photocure; QED Therapeutics; Taris
Research Funding - Photocure
Travel, Accommodations, Expenses - Photocure
 
Clint Cary
No Relationships to Disclose
 
Timothy A. Masterson
No Relationships to Disclose
 
Lawrence H. Einhorn
Stock and Other Ownership Interests - Amgen; Biogen
Consulting or Advisory Role - Celgene
 
Craig R. Nichols
No Relationships to Disclose
 
Christian K. Kollmannsberger
Honoraria - Bristol-Myers Squibb; Novartis; Pfizer
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Eisai; Ipsen; Janssen; Novartis; Pfizer
Travel, Accommodations, Expenses - Eisai; Novartis; Pfizer